Boston Scientific (BSX) Competitors $88.95 +0.29 (+0.33%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends BSX vs. ABT, ISRG, SYK, MDT, BDX, EW, IDXX, RMD, DXCM, and STEShould you be buying Boston Scientific stock or one of its competitors? The main competitors of Boston Scientific include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), and STERIS (STE). These companies are all part of the "health care equipment" industry. Boston Scientific vs. Abbott Laboratories Intuitive Surgical Stryker Medtronic Becton, Dickinson and Company Edwards Lifesciences IDEXX Laboratories ResMed DexCom STERIS Abbott Laboratories (NYSE:ABT) and Boston Scientific (NYSE:BSX) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, media sentiment, institutional ownership, risk, earnings, profitability, community ranking, analyst recommendations and valuation. Do insiders and institutionals hold more shares of ABT or BSX? 75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 1.1% of Abbott Laboratories shares are owned by company insiders. Comparatively, 0.5% of Boston Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media refer more to ABT or BSX? In the previous week, Boston Scientific had 6 more articles in the media than Abbott Laboratories. MarketBeat recorded 21 mentions for Boston Scientific and 15 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 0.84 beat Boston Scientific's score of 0.66 indicating that Abbott Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 9 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 4 Very Positive mention(s) 5 Positive mention(s) 9 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in ABT or BSX? Boston Scientific received 109 more outperform votes than Abbott Laboratories when rated by MarketBeat users. However, 69.70% of users gave Abbott Laboratories an outperform vote while only 69.67% of users gave Boston Scientific an outperform vote. CompanyUnderperformOutperformAbbott LaboratoriesOutperform Votes93469.70% Underperform Votes40630.30% Boston ScientificOutperform Votes104369.67% Underperform Votes45430.33% Is ABT or BSX more profitable? Abbott Laboratories has a net margin of 13.99% compared to Boston Scientific's net margin of 11.26%. Abbott Laboratories' return on equity of 20.18% beat Boston Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Abbott Laboratories13.99% 20.18% 10.84% Boston Scientific 11.26%17.23%9.52% Which has better valuation & earnings, ABT or BSX? Abbott Laboratories has higher revenue and earnings than Boston Scientific. Abbott Laboratories is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAbbott Laboratories$41.22B4.81$5.72B$3.2934.72Boston Scientific$15.91B8.24$1.59B$1.2173.51 Which has more volatility & risk, ABT or BSX? Abbott Laboratories has a beta of 0.73, indicating that its stock price is 27% less volatile than the S&P 500. Comparatively, Boston Scientific has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500. Do analysts recommend ABT or BSX? Abbott Laboratories currently has a consensus price target of $130.71, indicating a potential upside of 14.43%. Boston Scientific has a consensus price target of $95.96, indicating a potential upside of 7.88%. Given Abbott Laboratories' higher probable upside, equities research analysts clearly believe Abbott Laboratories is more favorable than Boston Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Abbott Laboratories 0 Sell rating(s) 4 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.73Boston Scientific 0 Sell rating(s) 3 Hold rating(s) 19 Buy rating(s) 1 Strong Buy rating(s) 2.91 SummaryAbbott Laboratories beats Boston Scientific on 10 of the 19 factors compared between the two stocks. Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Get Boston Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BSX vs. The Competition Export to ExcelMetricBoston ScientificSurgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$131.10B$4.36B$5.10B$19.18BDividend YieldN/A41.46%4.90%3.58%P/E Ratio73.5125.0190.8741.22Price / Sales8.2445.671,112.6717.58Price / Cash31.1943.4642.1421.28Price / Book6.677.364.785.32Net Income$1.59B$13.64M$119.77M$989.67M7 Day Performance-1.29%-2.82%-1.87%-3.45%1 Month Performance-2.83%0.54%11.46%-3.73%1 Year Performance59.92%41.80%30.49%12.06% Boston Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BSXBoston Scientific4.3401 of 5 stars$88.95+0.3%$95.96+7.9%+61.8%$131.10B$15.91B73.5148,000Analyst ForecastHigh Trading VolumeABTAbbott Laboratories4.9131 of 5 stars$113.49+0.1%$130.71+15.2%+6.4%$196.84B$41.22B34.46114,000Dividend IncreaseISRGIntuitive Surgical4.6784 of 5 stars$546.26+1.2%$550.28+0.7%+61.1%$194.57B$7.87B86.7513,676Analyst ForecastSYKStryker4.9654 of 5 stars$375.07+0.1%$404.35+7.8%+26.5%$142.98B$21.97B40.1852,000Analyst ForecastMDTMedtronic4.9528 of 5 stars$82.06-0.5%$95.27+16.1%+0.5%$105.22B$33.00B25.1495,000Analyst ForecastOptions VolumeBDXBecton, Dickinson and Company4.8867 of 5 stars$230.60+2.2%$283.50+22.9%-5.1%$66.67B$20.18B37.9774,000Analyst DowngradeInsider TradeAnalyst RevisionEWEdwards Lifesciences3.9397 of 5 stars$73.57+0.3%$79.40+7.9%+0.9%$43.39B$6.00B10.7419,800IDXXIDEXX Laboratories4.9808 of 5 stars$432.35+0.1%$539.63+24.8%-23.6%$35.40B$3.84B41.6711,000RMDResMed4.5281 of 5 stars$240.81+1.0%$227.91-5.4%+36.4%$35.35B$4.81B31.599,980Positive NewsDXCMDexCom4.9146 of 5 stars$76.42-1.0%$98.00+28.2%-31.4%$29.85B$3.95B46.229,600STESTERIS4.9352 of 5 stars$213.97-0.1%$262.50+22.7%-3.5%$21.12B$5.14B48.9118,179Positive News Related Companies and Tools Related Companies Abbott Laboratories Alternatives Intuitive Surgical Alternatives Stryker Alternatives Medtronic Alternatives Becton, Dickinson and Company Alternatives Edwards Lifesciences Alternatives IDEXX Laboratories Alternatives ResMed Alternatives DexCom Alternatives STERIS Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:BSX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Boston Scientific Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Boston Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
